The main goals of the present study were: (1) to estimate the impact of radical prostatectomy on biochemical recurrence- (BCR-) free and cancer-specific survival (CSS) rates of patients with PCa and PSA >20 ng/mL and (2) to identify a subset of patients who might have a favorable oncological outcome. Here, KLK3 is linked to posterior cortical atrophy.